Impact of chronic renin-angiotensin-aldosterone inhibitors on short-term outcomes in patients with acute heart failure presenting to the emergency department. A propensity-matched analysis EAHFE cohort
Antoni Haro,Javier Jacob,Xavier Rosselló,Pere Llorens,Pablo Herrero,Aitor Alquézar-Arbé,Lluis Llauger,Alfons Aguirre,Pascual Piñera,Begoña Espinosa,Víctor Gil,Guillermo Burillo-Putze,María Pilar López-Díez,Irene Cabello,Alex Roset,Enrique Martín-Mojarro,Juan Antonio Andueza,Josep Tost,Jose Manuel Garrido,Eva Domingo,Rafael Calvo-Rodríguez,Òscar Miró,ICA-SEMES Research Group,Marta Fuentes,Aitor Davila,Sonia Del Amo,Héctor Alonso,Enrique Pérez-Llantada,Francisco Javier Martín-Sánchez,Rosa Escoda,Carolina Sánchez,Daniel Repullo,Marta Masso,Javier Millán,Leticia Serrano,José Pavón,Nayra Cabrera González,Rafael Calvo Rodríguez,Juan Antonio Vega Reyes,María Luisa López-Grima,Amparo Valero,María Ángeles Juan,Silvia Mínguez Masó,Virginia Fernández-Távora Pérez,Ana Belén Mecina,Susana Sánchez Ramón,Virginia Carbajosa Rodríguez,José Andrés Sánchez Nicolás,Paula Lázaro Aragüés,Raquel Torres Garate,Esther Álvarez Rodríguez,Pilar Paz Arias,Sergio Herrera,Carlos José Romero Carrete,Antonio Haro,Lidia Fuentes,Fernando Richard,Elisa Fernández,María Pilar López Diez,Pablo Herrero Puente,Joaquín Vázquez Álvarez,Belén Prieto García,Alejandra Fernández Fernández,Belén Álvarez Ramos,Natalia Fernández Miranda,Sergio Guzmán,Gema Jara,Alba Felipe,Adriana Gil,Rodolfo Romero,Mariella Luengo López,Gema Domínguez,Martín Ruíz,Beatriz Amores Arriaga,Beatriz Sierra Bergua,Enrique Martín Mojarro,Lidia Cuevas Jiménez,Lisette Travería Bécquer,Guillermo Burillo,Lluís Llauger García,María De Los Ángeles González de la Torre,Carmen Esmeralda Romero Jiménez,Ester Soy Ferrer,María Adroher Múñoz,Francisco Javier Lucas-Imbernón,Rut Gaya,Carlos Bibiano,María Mir,Beatriz Rodríguez,Monika Vicente Martín,Esther Rodríguez Adrada,Eva Domingo Baldrich,Marianela Guzmán Carvajal,María José Fortuny,Yelenis Gómez García,Verónica de Las Nieves Segura Coronill,Marco Antonio Esquivias,María Del Carmen Martínez Picón,Marina Borox Callejas,Rocío Moyano García,Pablo Rodríguez,María Martínez Cuevas,José Noceda,Santiago Harris Blasco,Marta Romero,Jordi Estopá Valladares,Natalia Ramos González,Rocio Lorenzo,Juan Bautista Valencia,Lorena Bembibre,Inés Fernández Guerrero,José Manuel Garrido,Oriol Aguiló Pedret
DOI: https://doi.org/10.1016/j.ijcard.2024.132615
2025-01-01
Abstract:Objectives: The aim of the present study was to evaluate the impact of chronic treatment with angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) on short-term clinical outcomes after an episode of AHF. Methods: A secondary analysis of patients included in the EAHFE (Epidemiology of Acute Heart Failure in Emergency Departments) cohort, which includes patients diagnosed with AHF in 45 Spanish Emergency Departments (EDs). The primary outcome was all-cause in-hospital mortality. The secondary outcomes were all-cause death within 7 days, need for hospital admission and prolonged hospitalisation defined as a stay longer than or equal to 7 days. Multiple regression and propensity-matching was used for multivariate adjustment. Results: Of the 17,920 patients, 10,041 (56 %) were receiving chronic treatment with ACEI/ARB. The mean age was 80.4 years and 55.7 % were women. Adjusted odds ratios (aOR) were 0.76 (95 % CI 0.71-0.82) for in-hospital mortality witch multiple regression and 0.74 (95 %CI 0.63-0.88) with propensity-matching. aOR were 0.72; (95 %CI 0.65-0.79) and 0.70 (95 %CI 0.57-0.87) for mortality at the 7-day follow-up, respectively. The sensitivity analysis ACEI/ARB were associated with few all-cause deaths in patients with elevated natriuretic peptides in the EDs (aOR 0.74; 95 % CI 0.68-0.80), patients requiring hospital admission (aOR 0.78; 95 % CI 0.73-0.84) and patients with a history of HF (aOR 0.72; 95 % CI 0.66-0.78). Conclusions: Chronic use of ACEI/ARB was associated with better short-term outcomes in terms of all-cause in-hospital mortality in patients with AHF who attend an EDs.